Abstract | AIMS: METHODS: Forty-seven eyes of 47 consecutive patients with a BRVO who were treated with arteriovenous sheathotomy were studied. The patients were assigned prospectively to either Group R who received 30 mg of edaravone (Radicut) systemically during the vitrectomy or Group N who did not receive any drugs. The postoperative visual acuity was measured before and 12 months after the operation. RESULTS: At 12 months postoperatively, the best-corrected visual acuity (BCVA) in logarithm of the minimum angle of resolution (logMAR) units improved significantly from 0.22 to 0.56 logMAR units in Group R and from 0.20 to 0.27 units in Group N (p = 0.016). Twenty-three of 27 cases (85%) in Group R and four of 15 cases (27%) in Group N showed an improvement in BCVA of >0.2 logMAR units (p = 0.0025). CONCLUSION: The better visual acuity in patients given edaravone than those without endaravone during the arteriovenous sheathotomy suggests that edaravone improved the physiology of the retinal cells after the arteriovenous sheathotomy.
|
Authors | T Maeno, R Tano, H Takenaka, T Mano |
Journal | The British journal of ophthalmology
(Br J Ophthalmol)
Vol. 93
Issue 11
Pg. 1479-82
(Nov 2009)
ISSN: 1468-2079 [Electronic] England |
PMID | 19666924
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Free Radical Scavengers
- Edaravone
- Antipyrine
|
Topics |
- Adult
- Aged
- Antipyrine
(analogs & derivatives, therapeutic use)
- Edaravone
- Female
- Free Radical Scavengers
(therapeutic use)
- Humans
- Macular Edema
(drug therapy, etiology, surgery)
- Male
- Middle Aged
- Postoperative Care
- Retinal Vein Occlusion
(complications, physiopathology)
- Vascular Surgical Procedures
(methods)
- Visual Acuity
(drug effects)
- Vitrectomy
(methods)
|